Mach7 Delivers Positive Q2 FY26 Cashflow
Key points
- Commercial transformation well underway
- Operating cashflow positive in Q2 FY26
- First Flamingo Architecture customer secured
Full summary
Mach7 Technologies Limited (ASX:M7T) reported a strong Q2 FY26, with the company's commercial transformation well underway. Key highlights include operating cashflow turning positive in Q2 FY26, a significant improvement on Q1 FY26, and the company securing its first Flamingo Architecture customer in the quarter. Operating activity payments in Q2 FY26 were 9% lower than the prior corresponding period, driven by a 7% reduction in staff costs due to ongoing efficiencies. Contracted Annual Recurring Revenue (CARR) at 31 December 2025 was A$26.1M, down A$2.9M largely due to the discontinuation of the VHA's NextGen PACS program, while the company's Annual Recurring Revenue (ARR) Run Rate remained stable at A$23.0M. Mach7 ended the quarter with A$18.5M in cash and no debt. The company made progress on key strategic initiatives, including showcasing its Flamingo Architecture at RSNA 2025, signing its first Flamingo contract, re-energizing sales and marketing, and progressing towards Medical Device Regulation (MDR) compliance. Mach7 enters the second half of FY26 with a refined strategy, stronger operational foundation, and improving commercial momentum.
Outlook
Mach7 remains focused on disciplined cost management while selectively investing in growth-critical capabilities across sales, product development and platform scalability. The company is prioritizing financial discipline and efficient resource allocation to deliver against its strategy and capture emerging market opportunities.
Summary generated by a large language model. Please interpret with care.